Genomic instability in pluripotent stem cells: implications for clinical applications.
about
Using Stem Cells to Grow Artificial Tissue for Peripheral Nerve RepairSkeletal muscle generated from induced pluripotent stem cells - induction and application.Attenuated Innate Immunity in Embryonic Stem Cells and Its Implications in Developmental Biology and Regenerative Medicine.Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis.The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.Whole-genome mutational burden analysis of three pluripotency induction methods.Genetic stability of pluripotent stem cells during anti-cancer therapiesThe Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.Distinct Metabolic States Can Support Self-Renewal and Lipogenesis in Human Pluripotent Stem Cells under Different Culture ConditionsNeural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease.Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.Neural Stem Cells Derived From Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinsons Disease.Behavior of Xeno-Transplanted Undifferentiated Human Induced Pluripotent Stem Cells Is Impacted by Microenvironment Without Evidence of Tumors.Achilles' heel of pluripotent stem cells: genetic, genomic and epigenetic variations during prolonged culture.Patient-derived induced pluripotent stem cells in cancer research and precision oncology.Full biological characterization of human pluripotent stem cells will open the door to translational research.The tumorigenic potential of pluripotent stem cells: What can we do to minimize it?Reprogramming of Pancreatic Exocrine Cells AR42J Into Insulin-producing Cells Using mRNAs for Pdx1, Ngn3, and MafA Transcription Factors.A RHO Small GTPase Regulator ABR Secures Mitotic Fidelity in Human Embryonic Stem CellsCulture-induced recurrent epigenetic aberrations in human pluripotent stem cells.A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.Introduction to thematic minireview series: Development of human therapeutics based on induced pluripotent stem cell (iPSC) technology.Reducing genomic instability in iPSCsEngineered Livers for Infectious Diseases.Reconstituting Mouse Lungs with Conditionally Reprogrammed Human Bronchial Epithelial Cells.Quality Assured Characterization of Stem Cells for Safety in Banking for Clinical Application.Cardiac Cell Cycle Activation as a Strategy to Improve iPSC-Derived Cardiomyocyte Therapy.Human iPSC-Derived Posterior Gut Progenitors Are Expandable and Capable of Forming Gut and Liver Organoids.Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.Generation of functional cardiomyocytes from rat embryonic and induced pluripotent stem cells using feeder-free expansion and differentiation in suspension culture.
P2860
Q26747035-6F13BBE1-0423-4460-AC49-C80B172566CAQ33854768-066BC9E5-0A09-4114-98E2-C1FF3ED877DBQ36199901-BB642281-2114-44A3-857D-74A90CE5A3C4Q36255345-6D90A531-93EA-433C-8C1B-8ABEE4C81248Q36321047-768DD8BD-E577-4940-A6E5-D242306A5699Q36605066-EB332B6A-63DA-4873-8CDB-D78BAF7048E0Q36639903-36EA488B-7994-4BA5-BFA6-CC91654542C8Q36695546-001372E9-B1EA-41FF-B0F1-D5D8067AD746Q37168323-4DFAD9D1-F2F8-48F0-AEE2-16371B7E29C6Q37320881-73F898C9-543F-4F82-A46C-04F720989FF3Q37378179-DC74F0C5-7809-4A11-BB35-CE084BE9A8D9Q37735796-65E7E097-CBA7-42C0-9464-80C51F0A2EADQ38383700-67357A90-EA04-4841-A4C9-234FF4AEC862Q38685965-8B388EDC-7EDD-4FA3-B042-E29C8C69D356Q38767506-A1A7472E-8DFD-4725-931B-9E4D4F67A5BCQ38786566-98BF19D1-3779-4483-9A64-29D1E6A939D8Q38871443-675C5728-5EE3-4717-AD9C-F571EBB3D4AEQ38896951-B04F77AE-A2ED-4FBB-9798-9DC5F4052086Q40750820-E18EAD58-17E2-4E6C-8A11-01822C2B32ACQ41018816-4C3D9057-234B-460E-B561-EA291AEF2441Q41635361-0F1FA9F6-48D2-4B34-88C0-928985EEEE17Q42376493-05F80FA3-14F4-473F-99BA-CDA3C2465310Q42434697-F656FEBA-9653-402C-9C1B-FC67D0B41338Q42551585-6E9F5420-6EDB-4425-B4F5-CBA92A169C92Q47555660-91E8B3F2-5A1B-4A95-A9F7-D1C8B225E4D8Q47827372-EB0681A5-97D7-463B-9D19-C082AE03FB18Q48239641-E6C3D192-AA03-479C-A537-C8332B8FE746Q48550029-ADB39839-17FD-4636-B127-105B941FE28DQ50074648-A46A0003-EB05-4D3E-BE3C-6BC7941C3C21Q52589683-6629DFD9-4B2F-476C-956E-65F9A8FC6E57Q54949440-35F62147-3247-4C50-B971-D92DB8E9497B
P2860
Genomic instability in pluripotent stem cells: implications for clinical applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genomic instability in pluripotent stem cells: implications for clinical applications.
@en
Genomic instability in pluripotent stem cells: implications for clinical applications.
@nl
type
label
Genomic instability in pluripotent stem cells: implications for clinical applications.
@en
Genomic instability in pluripotent stem cells: implications for clinical applications.
@nl
prefLabel
Genomic instability in pluripotent stem cells: implications for clinical applications.
@en
Genomic instability in pluripotent stem cells: implications for clinical applications.
@nl
P2860
P356
P1476
Genomic instability in pluripotent stem cells: implications for clinical applications.
@en
P2093
Jeanne F Loring
Suzanne E Peterson
P2860
P304
P356
10.1074/JBC.R113.516419
P407
P577
2013-12-20T00:00:00Z